ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity.

Maher G Nawaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.